Study
| EST. READ TIME 1 MIN.Canada's Drug Price Paradox, 2007
Canadians pay much more than Americans for generic drugs because government policies in Canada distort the market for prescription medicines. In currency-equivalent terms, Canadian retail prices for generic prescription drugs in 2006 were on average 115% higher than retail prices observed in the United States for identical drugs. A previous analysis using 2003 data found that prices for generic drugs were 78% higher in Canada. By contrast, Canadian retail prices for brand-name drugs were on average 51% below US prices for identical drugs in 2006. In 2003, the prices for brand-name drugs was 43% lower in Canada on average. For Canadians, this means that since 2003 the cost of generic drugs has risen relative to US prices, while the cost of brand-name drugs has decreased.
Share
-
Brett J. Skinner
Brett J. Skinner Dr. Brett J. Skinner was the Fraser Institutes Director of Health Policy Research (2004 to 2012) andwas also the Institutes President and CEO (2010 and 2012). Dr. Skinner has a B.A. from the University of Windsor, an M.A. through joint studies between the University of Windsor and Wayne State University in Detroit (Michigan), and a Ph.D. from the University of Western Ontario, where he has lectured in both the Faculty of Health Sciences and the Department of Political Science. Dr. Skinner has authored or co-authored approximately 50 major original pieces of applied economics and public policy research. In 2003 he was a co-winner of the Atlas Economic Research Foundations Sir Antony Fisher Memorial Award for innovative projects in public policy. Dr. Skinners book, Canadian Health Policy Failures: Whats wrong? Who gets hurt? Why nothing changes, was a finalist for Atlas 2009 Fisher book prize. His research has been published through several think-tanks including the Fraser Institute (Vancouver), the Atlantic Institute for Market Studies (Halifax), the Pacific Research Institute (San Francisco), the American Enterprise Institute (Washington, D.C.) and the Israel National Institute for Health Policy Research (Israel). His work has also been published in several academic journals including Economic Affairs, Pharmacoeconomics and Alimentary Pharmacology & Therapeutics. Dr. Skinner appears and is cited frequently as an expert in the Canadian, American, and global media. He has presented his research at conferences and events around the world, including testifying before the House of Commons Standing Committee on Health in Ottawa, and briefing bi-partisan Congressional policy staff at the U.S. Capitol in Washington, D.C.… Read more Read Less… -
Mark Rovere
Related Topics
Related Articles
By: Dr. Jehangir Appoo, Glen Sumner and Aria S. Appoo
By: Bacchus Barua and Mackenzie Moir
By: Bacchus Barua and Mackenzie Moir
By: Mackenzie Moir